A PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROPOIETIN AND CEFTRIAXONE AND A USE THEREOF IN THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PARKINSONS DISEASE DEMENTIA
This invention discloses that a combination of ceftriaxone and erythropoietin can be used in the treatment and/or prevention of Parkinson’s disease dementia (PDD).